Sunny Kumar
Partner @ Informed Ventures
Palo Alto, United States
Sunny Kumar is a Series A investor at Informed Ventures in Palo Alto focused on Artificial Intelligence and Software. Sunny Kumar is based out of Palo Alto, California and is a Partner at GSR Ventures. Sunny brings a unique background as a Stanford-trained physician, having focused his career on bridging the gap between cutting-edge research and real-world impact, with pioneering work at the intersection of informatics, artificial intelligence, and translationalmedicine. Sunny Kumar attended Yale University for his Bachelor of Science in Molecular, Cellular, and Developmental Biology, Stanford University School of Medicine for his Doctor of Medicine degree, and Stanford University Graduate School of Business for his Master of Business Administration
- Total investments:
- 16
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Sunny Kumar invests in
Stages Sunny Kumar invests in
Countries Sunny Kumar invests in
Investment Focus
Industry
- Artificial Intelligence 4 (25%)
- Software 3 (19%)
- Machine Learning 3 (19%)
- Medical 2 (13%)
- Robotics 2 (13%)
Stage
- Series A 4 (25%)
- Series B 3 (19%)
- Seed 2 (13%)
- Series C 2 (13%)
- Pre-Seed 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Autopoiesis Sciences
|
Autopoiesis Sciences builds next-generation AI models designed to unlock transformative scientific breakthroughs across all critical research domains. The company's approach focuses on developing foundational reasoning capabilities that can autonomously drive discovery in areas where traditional AI has failed to deliver reliable results. | Pre-Seed / Jul 30, 2025 | |
|
Autopoiesis Sciences
|
Autopoiesis Sciences builds next-generation AI models designed to unlock transformative scientific breakthroughs across all critical research domains. The company's approach focuses on developing foundational reasoning capabilities that can autonomously drive discovery in areas where traditional AI has failed to deliver reliable results. | Seed / Jul 30, 2025 | |
Nimble Robotics
|
Nimble builds AI-powered robots that pick and pack anything to enable the fastest, most affordable, and most sustainable on-demand order fulfillment. | Series B / Mar 16, 2023 | |
Nimble Robotics
|
Nimble Robotics specializes in AI-driven robots that automate the processes of picking and packing products, significantly enhancing efficiency in logistics. The company provides a complete eCommerce and omni-channel fulfillment service, allowing merchants to streamline their operations. | $65M / Series B / Mar 16, 2023 | |
Osso VR
|
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices. | $66M / Series C / Mar 24, 2022 | |
HealthRhythms
|
HealthRhythms develops a mental health assessment and treatment platform to measure and monitor health conditions. The company's solution utilizes deep machine learning and predictive analytics to create novel health assessments and just-in-time personalized interventions that improve the care delivery experience for patients, health plans,payers, and research organizations. | $11M / Seed / Feb 02, 2022 | |
Medable
|
Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Itis now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages.It was founded in 2015 and is headquartered in Palo Alto, California. | $304M / Series D / Oct 26, 2021 | |
|
Osso VR
|
Osso VR is a surgical training and assessment platform that uses advanced virtual reality to train and assess medical personnel. Their product offers realistic hand-based interactions in an immersive training environment containing cutting-edge procedures and devices. | $27M / Series B / Jul 07, 2021 | |
|
Medable
|
Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Itis now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages.It was founded in 2015 and is headquartered in Palo Alto, California. | $78M / Series C / Apr 15, 2021 | |
|
Nimble Robotics
|
Nimble builds AI-powered robots that pick and pack anything to enable the fastest, most affordable, and most sustainable on-demand order fulfillment. | $50M / Series A / Mar 11, 2021 | |
| See all 16 investments → | |||
Co-Investors
Sapphire Ventures
5 deals together
DNS Capital
4 deals together
Streamlined
4 deals together
PPD clinical research business of Thermo Fisher Scientific
3 deals together
Blackstone Accelerates Growth
2 deals together
Breyer Capital
2 deals together
About Informed Ventures
Informed Ventures is a Menlo Park-based venture capital firm specializing in early-stage transformative companies across digital health, SaaS, and artificial intelligence applications.
Informed Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Yuechen Zhao
Partner
|
|||
Richard Lim
Managing Director & Founder
|
|||
|
Sunny Kumar
Partner
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sunny Kumar invest in?
Sunny Kumar invests primarily in Artificial Intelligence, Software and Machine Learning startups, most often at Series A and Series B stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sunny Kumar last invest?
The most recent investment recorded for Sunny Kumar closed in Jul 2025. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
